Patents Assigned to Coherus Biosciences, Inc.
  • Stable Aqueous Etanercept Composition
    Publication number: 20190290768
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: June 14, 2019
    Publication date: September 26, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • Stable Aqueous Etanercept Composition
    Publication number: 20190290766
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: June 14, 2019
    Publication date: September 26, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • Method of Reducing Formation of Etanercept Aggregates or Fragments
    Publication number: 20190290765
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: June 14, 2019
    Publication date: September 26, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • Method of Reducing Formation of Etanercept Aggregates or Fragments
    Publication number: 20190290767
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: June 14, 2019
    Publication date: September 26, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark MANNING, Brian Murphy
  • Etanercept formulations stabilized with combinations of sugars and polyols
    Patent number: 10376588
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: March 9, 2018
    Date of Patent: August 13, 2019
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • ETANERCEPT FORMULATIONS STABILIZED WITH AMINO ACIDS
    Publication number: 20190216930
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions stabilized with an amino acid and suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: March 21, 2019
    Publication date: July 18, 2019
    Applicant: COHERUS BIOSCIENCES, INC.
    Inventors: Mark MANNING, Brian MURPHY
  • ETANERCEPT FORMULATIONS STABILIZED WITH XYLITOL
    Publication number: 20190184017
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: February 25, 2019
    Publication date: June 20, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark MANNING, Brian Murphy
  • Etanercept formulations stabilized with amino acids
    Patent number: 10293049
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions stabilized with an amino acid and suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 18, 2012
    Date of Patent: May 21, 2019
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • Methods of manufacturing stable aqueous formulations of adalimumab
    Patent number: 10286072
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: May 14, 2019
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Syringe containing stable aqueous formulations of adalimumab
    Patent number: 10286071
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 10, 2017
    Date of Patent: May 14, 2019
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB
    Publication number: 20190070293
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: November 1, 2018
    Publication date: March 7, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB
    Publication number: 20190070294
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: November 1, 2018
    Publication date: March 7, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB
    Publication number: 20190070292
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: November 1, 2018
    Publication date: March 7, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • STABLE AQUEOUS FORMULATIONS OF ADALIMUMAB
    Publication number: 20190060455
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Application
    Filed: November 1, 2018
    Publication date: February 28, 2019
    Applicant: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Etanercept formulations stabilized with xylitol
    Patent number: 10213508
    Abstract: The invention provides stabilized aqueous pharmaceutical etanercept compositions suitable for long-term storage of etanercept, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: February 26, 2019
    Assignee: Coherus BioSciences, Inc.
    Inventors: Mark Manning, Brian Murphy
  • Stable aqueous formulations of adalimumab
    Patent number: 10207000
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: February 19, 2019
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 10195275
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: January 9, 2018
    Date of Patent: February 5, 2019
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 10159733
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: December 25, 2018
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 10159732
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: December 25, 2018
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne
  • Stable aqueous formulations of adalimumab
    Patent number: 10155039
    Abstract: The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: December 18, 2018
    Assignee: Coherus Biosciences, Inc.
    Inventors: Mark Manning, Robert W. Payne